Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT00944281Not ApplicableCompleted

Optimal Amount of Zinc to Include in a Lipid-based Nutrient Supplement (LNS)

Role: collaborator

NCT00944359Not ApplicableCompleted

Impact of Preventive and Therapeutic Zinc Supplementation Programs Among Young Children

Role: collaborator

NCT03482869Not ApplicableUnknown

Evaluation of Self-reported Walking Impairment in Predominantly Illiterate Patients

Role: lead

NCT00944853Not ApplicableCompleted

Effects of Liquid Zinc Supplementation and Dispersible Zinc Tablets on Plasma Zinc Concentration

Role: collaborator

NCT00944814Not ApplicableCompleted

Acceptability of Zinc-fortified Lipid-based Nutrient Supplements

Role: collaborator

NCT01255605Completed

Impact of IPT With Sulfadoxin Pyrimetamin on Pregnant Women and Their Babies Outcomes in Peri-urban Areas of Bobo-Dioulasso(Burkina Faso)

Role: lead

All 6 trials loaded